Maryland Heights, MO, March 11, 2017 --(PR.com
)-- The global immunoprotein diagnostic testing market is estimated to reach USD 15.8 Billion in 2020, expanding at a CAGR of 4.3% from 2016 to 2020, due to higher incidence of chronic infections worldwide.
Browse Immunoprotein Diagnostic Testing Market by Assay Technologies (Chemiluminescence Assay, Enzyme Based Immunoassay, Immunofluorescence Assay, Immunoprotein Electrophoresis, Immunoturbidity Assay, Radioimmunoassay), Immunoprotein Types (Complement System Proteins Diagnostic Tests, C-Reactive Protein Diagnostic Tests, Free Light Chain Diagnostic Tests, Haptoglobin Diagnostic Tests, Immunoglobulin Diagnostic Tests, Prealbumin Diagnostic Tests), and Applications (Allergy Testing, Autoimmune Disease Testing, Endocrine Testing, Infectious Disease Testing, Oncology Testing, Toxicology Testing) 2016-2020 at https://www.ihealthcareanalyst.com/report/immunoprotein-diagnostic-testing-market/
Immunoassays are laboratory techniques based on the detection of antibody production in response to foreign antigens. Antibodies, part of the humoral immune response, are involved in pathogen detection and neutralization. Serology is the study of blood serum and other bodily fluids for the identification of antibodies. The applications of immunostaining are numerous, but are most typically used in clinical diagnostics and laboratory research. These biochemical and serological techniques are based on the detection and quantitation of antibodies generated against an infectious agent, a microbe, or non-microbial antigen.
The global immunoprotein diagnostic testing market segmentation is based on assay technologies (chemiluminescence assay, enzyme based immunoassay, immunofluorescence assay, immunoprotein electrophoresis, immunoturbidity assay, radioimmunoassay), immunoprotein types (complement system proteins diagnostic tests, c-reactive protein diagnostic tests, free light chain diagnostic tests, haptoglobin diagnostic tests, immunoglobulin diagnostic tests, prealbumin diagnostic tests), and applications (allergy testing, autoimmune disease testing, endocrine testing, infectious disease testing, oncology testing, toxicology testing).
The global immunoprotein diagnostic testing market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global immunoprotein diagnostic testing market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global immunoprotein diagnostic testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global immunoprotein diagnostic testing market and included in this report are Abbott Laboratories, Abcam PLC, DiaSorin, Enzo Life Sciences, Randox Laboratories, Roche, Siemens, The Binding Site, and Thermo Fisher Scientific.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043